Scientific Conferences for The College on Problems of Drug Dependence (CPDD)
药物依赖问题学院科学会议(CPDD)
基本信息
- 批准号:10610865
- 负责人:
- 金额:$ 9.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:AcademiaAccelerationAddressAdministratorAdoptedAlcoholsAnimalsAnti-Anxiety AgentsAreaAwardBehaviorCannabisCareer MobilityClinicalCollaborationsComputer softwareCountryDedicationsDevelopmentDisciplineDrug AddictionEpidemiologyEquipmentFosteringFundingFutureGeneticGovernmentGrantHIV/AIDSHallucinogensHealth ServicesHumanIndustryInternationalKnowledgeLearningMedicineMentorsMissionMolecular BiologyNational Institute of Drug AbuseNatureNeurosciencesNicotineNursesOnline SystemsOpioidParticipantPharmaceutical ChemistryPharmaceutical PreparationsPharmacologyPhysiciansPoliciesPolicy MakerPreventionPsychologistPsychologyPublic HealthPublic PolicyResearchResearch PersonnelScientific SocietiesScientistSociologyStimulantSubstance Use DisorderTraining ActivityTravelUnderrepresented MinorityUnderrepresented PopulationsUnited Statesaddictioncareercareer developmentcollegedoctoral studentdrug of abuseepidemiology studyexperiencehealth disparityhypnoticimprovedinnovationinterestlecturesmeetingsneuroimagingoutreachposterspre-doctoralprogramsresearch studysedativesubstance usesubstance use treatmentsymposiumtranslational studytreatment researchvirtual
项目摘要
ABSTRACT
This is a request for a 5-year renewal of grant R13DA013192 to continue to support travel awards for
trainees and early career researchers to attend annual meetings of the College on Problems of Drug
Dependence (CPDD). CPDD is the oldest scientific society dedicated to substance use research. As
the only annual national or international meeting that brings together researchers studying all aspects
and approaches to the problems of substance use, CPDD’s conference provides a particularly
enriching experience for trainees and early career researchers in the field. The meeting attracts basic
and clinical researchers from throughout the United States and about 40 countries, at all career stages
from predoctoral students through senior investigators, as well as representatives from government and
industry. It includes scientists, physicians, nurses, clinical psychologists, administrators, policy makers,
journalists and others working on or interested in substance use research. Our meetings are a forum for
researchers from a broad range of disciplines (e.g., medicinal chemistry, molecular biology,
pharmacology, genetics, neuroimaging, psychology, sociology, addiction medicine, public health,
epidemiology) to share their recent findings, network and learn from one another in formal and informal
exchanges. We expect 1000-1300 attendees at each of our future meetings supported by this
competing renewal. In the next funding period, we propose to continue to support travel awards for
trainees and early career researchers to attend the CPDD annual meetings. Topics addressed at the
meeting change with emerging concerns and cutting-edge research in the field, and, each year,
sessions highly relevant to NIDA's major program areas (e.g., epidemiology, prevention, health
services, medications development, neuroscience, behavior, HIV/AIDS and health disparities) are
included. Presentations span the full range of drugs of abuse, including opioids, stimulants, sedatives,
cannabis, hallucinogens, nicotine and alcohol. The conference includes awards lectures and forums on
policy, animal and human research, industry/academia/government collaboration and media outreach,
as well as activities directed towards trainees, early career researchers, underrepresented minorities
and international scientists. We expect our annual meetings to accelerate innovation in substance use
research through the translational nature of our content and through the collaborations that are built
between attendees across the disciplines represented at the meeting. We also expect findings
presented at the meeting to reach a broader audience due to our media outreach activities and newly
developed virtual offerings, which can significantly improve prevention and treatment of substance use
disorders and inform policy as it relates to substance use.
抽象的
这是一项将拨款 R13DA013192 续签 5 年的请求,以继续支持以下人员的旅行奖励:
学员和早期职业研究人员参加毒品问题学院年会
依赖性 (CPDD) 是最古老的致力于药物使用研究的科学协会。
唯一汇集研究各个方面的研究人员的年度国内或国际会议
和解决物质使用问题的方法,CPDD 会议提供了一个特别的
这次会议吸引了基础知识,丰富了该领域的学员和早期职业研究人员的经验。
以及来自美国各地和约 40 个国家/地区各个职业阶段的临床研究人员
从博士前学生到高级研究人员,以及来自政府和机构的代表
它包括科学家、医生、护士、临床心理学家、管理人员、政策制定者、
我们的会议是从事药物使用研究或对药物使用研究感兴趣的记者和其他人的论坛。
来自广泛学科的研究人员(例如药物化学、分子生物学、
药理学、遗传学、神经影像学、心理学、社会学、成瘾医学、公共卫生、
流行病学)以正式和非正式的方式分享他们的最新发现、建立联系并相互学习
我们预计未来每次会议将有 1000-1300 名与会者。
在下一个资助期内,我们建议继续支持旅行奖励。
学员和早期职业研究人员参加 CPDD 年会讨论的主题。
应对该领域新出现的问题和前沿研究的变化,并且每年,
与 NIDA 的主要计划领域(例如流行病学、预防、健康
服务、药物开发、神经科学、行为、艾滋病毒/艾滋病和健康差异)
演示涵盖了各种滥用药物,包括阿片类药物、兴奋剂、镇静剂、
会议包括有关大麻、致幻剂、尼古丁和酒精的颁奖讲座和论坛。
政策、动物和人类研究、工业/学术界/政府合作和媒体宣传,
以及针对受训人员、早期职业研究人员、代表性不足的少数群体的活动
我们期望我们的年度会议能够加速药物使用的创新。
通过我们内容的翻译性质和建立的合作进行研究
我们还期待会议中不同学科的与会者之间的调查结果。
由于我们的媒体宣传活动和新的
开发虚拟产品,可以显着改善药物滥用的预防和治疗
疾病并为与药物使用相关的政策提供信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DEBORAH S HASIN其他文献
DEBORAH S HASIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DEBORAH S HASIN', 18)}}的其他基金
COVID-19, heavy drinking and alcohol use disorders: a national study of Veterans Administration patients
COVID-19、酗酒和酒精使用障碍:一项针对退伍军人管理局患者的全国研究
- 批准号:
10371482 - 财政年份:2022
- 资助金额:
$ 9.5万 - 项目类别:
COVID-19, heavy drinking and alcohol use disorders: a national study of Veterans Administration patients
COVID-19、酗酒和酒精使用障碍:一项针对退伍军人管理局患者的全国研究
- 批准号:
10596115 - 财政年份:2022
- 资助金额:
$ 9.5万 - 项目类别:
Impact of Medical and Recreational Marijuana Laws On Cannabis, Opioids And Psychiatric Medications: National Study of VA Patients, 2000 - 2024
医用和娱乐大麻法对大麻、阿片类药物和精神药物的影响:2000 年至 2024 年退伍军人事务部患者的全国研究
- 批准号:
10393578 - 财政年份:2019
- 资助金额:
$ 9.5万 - 项目类别:
Impact of Medical and Recreational Marijuana Laws On Cannabis, Opioids And Psychiatric Medications: National Study of VA Patients, 2000 - 2024
医用和娱乐大麻法对大麻、阿片类药物和精神药物的影响:2000 年至 2024 年退伍军人事务部患者的全国研究
- 批准号:
10612385 - 财政年份:2019
- 资助金额:
$ 9.5万 - 项目类别:
Drinking levels (binge, volume) and alcohol consequences: using national data to identify clinical trial endpoints - Administrative Supplement
饮酒水平(酗酒、饮酒量)和酒精后果:使用国家数据确定临床试验终点 - 行政补充
- 批准号:
10228425 - 财政年份:2016
- 资助金额:
$ 9.5万 - 项目类别:
Drinking levels (binge, volume) and alcohol consequences: using national data to identify clinical trial endpoints
饮酒水平(酗酒、饮酒量)和酒精后果:使用国家数据确定临床试验终点
- 批准号:
9440313 - 财政年份:2016
- 资助金额:
$ 9.5万 - 项目类别:
Drinking levels (binge, volume) and alcohol consequences: using national data to identify clinical trial endpoints
饮酒水平(酗酒、饮酒量)和酒精后果:使用国家数据确定临床试验终点
- 批准号:
9883624 - 财政年份:2016
- 资助金额:
$ 9.5万 - 项目类别:
HealthCall: Enhancing brief intervention for HIV primary care alcohol dependence
HealthCall:加强对艾滋病毒初级保健酒精依赖的短期干预
- 批准号:
9317400 - 财政年份:2014
- 资助金额:
$ 9.5万 - 项目类别:
HealthCall: Enhancing brief intervention for HIV primary care alcohol dependence
HealthCall:加强对艾滋病毒初级保健酒精依赖的短期干预
- 批准号:
8932642 - 财政年份:2014
- 资助金额:
$ 9.5万 - 项目类别:
HealthCall: Enhancing brief intervention for HIV primary care alcohol dependence
HealthCall:加强对艾滋病毒初级保健酒精依赖的短期干预
- 批准号:
8731034 - 财政年份:2014
- 资助金额:
$ 9.5万 - 项目类别:
相似国自然基金
基于增广拉格朗日函数的加速分裂算法及其应用研究
- 批准号:12371300
- 批准年份:2023
- 资助金额:43.5 万元
- 项目类别:面上项目
肠菌源性丁酸上调IL-22促进肠干细胞增殖加速放射性肠损伤修复的机制研究
- 批准号:82304065
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于肌红蛋白构象及其氧化还原体系探究tt-DDE加速生鲜牛肉肉色劣变的分子机制
- 批准号:32372384
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于联邦学习自动超参调整的数据流通赋能加速研究
- 批准号:62302265
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
M2 TAMs分泌的OGT通过促进糖酵解过程加速肝细胞癌恶性生物学行为的机制研究
- 批准号:82360529
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Supplement: Enhancing Community Contributions to Bioconductor With Build System Containerization and a GPU for Testing
补充:通过构建系统容器化和用于测试的 GPU 增强社区对 Bioconductor 的贡献
- 批准号:
10838736 - 财政年份:2023
- 资助金额:
$ 9.5万 - 项目类别:
2023 Neurotrophic Mechanisms in Health and Disease
2023 健康与疾病中的神经营养机制
- 批准号:
10654336 - 财政年份:2023
- 资助金额:
$ 9.5万 - 项目类别:
2023 Silk Proteins and the Transition to Biotechnologies Gordon Research Conference
2023 年丝蛋白和向生物技术的过渡戈登研究会议
- 批准号:
10681751 - 财政年份:2023
- 资助金额:
$ 9.5万 - 项目类别:
Accelerating URiA Independent Research Potential in Nutrition Sciences
加速 URiA 在营养科学方面的独立研究潜力
- 批准号:
10746637 - 财政年份:2023
- 资助金额:
$ 9.5万 - 项目类别: